News

Septalyst wins award for Fastest Growing Nephrology Company

Septalyst

Septalyst Lifesciencs Pvt. Ltd., a Mumbai based super-speciality pharmaceutical company focusing on Nephro, Neuro & Critical care products & therapy has bagged the award for “Fastest Growing Company of the year in Nephrology” at the seventh edition of CIMS Healthcare Excellence Awards held in Mumbai.

Septalyst

Speaking about the award, Shyam Sunder Singh, MD & CEO, Septalyst said, “It is indeed a moment of pride & pleasure to be recognized for our good work. I dedicate this award to my team for their hard work & commitment. We are now even more motivated to work with missionary zeal and commitment and achieve bigger heights in future. Unique products, very strong sales team and focus on secondary sales are the main factors which led to very rapid growth of the company.”

Septalyst started its operations in 2010 and in a short span of time has carved a niche in Nephro & Critical care segments. Today, it is the fastest growing company in the field of Nephrology & ranked amongst the top 12 players in Indian Nephrology. With a team size of 200 highly talented professionals, a strong network of 30 sales depot & 150 stockists across India, it is all set for rapid growth & expansion.

Recently Septalyst launched Central Nervous System (CNS) division in 10 states with 18 products in Neuro & psychiatry range. By December 2017, it plans to have a pan India presence in CNS with a field force of 250 people. Septalyst is confident that with its therapy centric business model, professional work culture & motivated sales force, it will soon become a leading player in the CNS segment also.

The company is promoted by young entrepreneurs having wide experience & exposure in exports & domestic pharmaceutical industry. Founder Director Shyam Sunder Singh has a vast experience of 20 years in retail, supply chain & pharmaceutical industry.

Don't be shellfish...Share on Facebook0Share on Google+0Share on LinkedIn0Share on StumbleUpon0Pin on Pinterest0Tweet about this on Twitter0
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>

Most Popular

To Top